Examkin

Question

Difficulty: MediumSchizophrenia and Psychotic Disorders

A 24-year-old woman is newly diagnosed with schizophrenia after presenting with persistent auditory hallucinations and persecutory delusions. The treatment team outlines a comprehensive, stepwise pharmacological management plan for her condition, anticipating the possibility of treatment resistance at each stage. Arrange the following therapeutic steps in the standard sequential order they should be implemented, assuming the patient continues to have severe, unrelenting symptoms despite documented adherence to each prior intervention.

  1. 1Administer an initial 6-week trial of oral risperidone monotherapy.
  2. 2Administer a 6-week trial of oral aripiprazole monotherapy.
  3. 3Initiate oral clozapine with absolute neutrophil count monitoring.
  4. 4Augment the medication regimen with electroconvulsive therapy (ECT).

Answer

The correct sequence is: 1) Initial trial of risperidone monotherapy, 2) Trial of aripiprazole monotherapy, 3) Initiation of clozapine, 4) Augmentation with ECT.
The correct algorithm for managing schizophrenia begins with a trial of a first-line antipsychotic (e.g., risperidone). If the initial trial fails, a second trial with a different antipsychotic (e.g., aripiprazole) is indicated. Treatment-resistant schizophrenia is defined by the failure of at least two adequate trials of different antipsychotics; at this stage, clozapine is the treatment of choice. Finally, if the patient continues to experience refractory symptoms on an adequate dose of clozapine, augmentation strategies such as ECT are utilized.

Step-by-Step Solution

1
Identify the appropriate initial therapy for a newly diagnosed patient with schizophrenia.
The first step is a trial of a first-line antipsychotic, such as oral risperidone monotherapy.
Second-generation antipsychotics have favorable efficacy and side-effect profiles for initial treatment.
2
Determine the next step if the initial 6-week trial is ineffective.
The patient should be switched to a different first- or second-generation antipsychotic, such as oral aripiprazole monotherapy.
Failure of one antipsychotic does not indicate treatment resistance. A second, different monotherapy trial is required.
3
Recognize the criteria for treatment-resistant schizophrenia.
After failing two adequate trials of different antipsychotics, the patient should be prescribed clozapine.
Clozapine is uniquely effective for treatment-resistant schizophrenia and reducing suicidal behavior, despite requiring strict hematologic monitoring.
4
Formulate a plan for clozapine refractoriness.
If symptoms persist despite an adequate clozapine trial, the final step is augmentation with electroconvulsive therapy (ECT) or a second antipsychotic.
ECT is a well-established, evidence-based augmentation strategy for clozapine-resistant schizophrenia.

Key Concept

The stepwise pharmacological management of schizophrenia involves sequential trials of different antipsychotics, followed by clozapine for treatment resistance, and finally clozapine augmentation strategies.
Estimated Time:1m 0s
Rate this question

Topics

Schizophrenia and Psychotic Disorders

More questions from this topic